You have Guest access.
Log In
Mark K. Ferguson
i-xx
Front matter
3-55
Part 1 / Background
3-12
Introduction
13-20
Evidence-Based Medicine: Levels of Evidence and Grades of Recommendation
21-35
Decision Analytic Techniques
36-43
Nonclinical Components of Surgical Decision Making
44-55
How Patients Make Decisions with Their Surgeons: The Role of Counseling and Patient Decision Aids
59-192
Part 2 / Lung
59-67
Radiographic Staging of Lung Cancer: Computed Tomography and Positron Emission Tomography
68-74
Routine Mediastinoscopy for Clinical Stage I Lung Cancer
75-81
Management of Unexpected N2 Disease Discovered at Thoracotomy
82-87
Induction Therapy for Clinical Stage I Lung Cancer
88-93
Induction Therapy for Stage IIIA (N2) Lung Cancer
94-102
Adjuvant Postoperative Therapy for Completely Resected Stage I Lung Cancer
103-109
Sleeve Lobectomy Versus Pneumonectomy for Lung Cancer Patients with Good Pulmonary Function
110-118
Lesser Resection Versus Lobectomy for Stage I Lung Cancer in Patients with Good Pulmonary Function
119-127
Lesser Resection Versus Radiotherapy for Patients with Compromised Lung Function and Stage I Lung Cancer
128-139
Resection for Patients Initially Diagnosed with N3 Lung Cancer after Response to Induction Therapy
140-146
Video-Assisted Thorascopic Surgery Major Lung Resections
147-150
Surgery for Non-Small Cell Lung Cancer with Solitary M1 Disease
151-157
Thoracoscopy Versus the Open Approach for Resection of Solitary Pulmonary Metastases
158-164
Unilateral or Bilateral Approach for Unilateral Pulmonary Metastatic Disease
165-174
Surgery for Bronchoalveolar Lung Cancer
175-185
Lung Volume Reduction Surgery in the Candidate for Lung Transplantation
186-192
Pleural Sclerosis for the Management of Initial Pneumothorax
195-339
Part 3 / Esophagus
195-199
Staging for Esophageal Cancer: Positron Emission Tomography, Endoscopic Ultrasonography
200-207
Induction Therapy for Resectable Esophageal Cancer
208-217
Transthoracic Versus Transhiatal Resection for Carcinoma of the Esophagus
218-224
Minimally Invasive Versus Open Esophagectomy for Cancer
225-233
Lymph Node Dissection for Carcinoma of the Esophagus
234-241
Intrathoracic Versus Cervical Anastomosis in Esophageal Replacement
242-249
Jejunostomy after Esophagectomy
250-257
Gastric Emptying Procedures after Esophagectomy
258-264
Posterior Mediastinal or Retrosternal Reconstruction Following Esophagectomy for Cancer
265-270
Postoperative Adjuvant Therapy for Completely Resected Esophageal Cancer
271-278
Celiac Lymph Nodes and Esophageal Cancer
279-284
Partial or Total Fundoplication for Gastroesophageal Reflux Disease in the Presence of Impaired Esophageal Motility
285-291
Botox, Balloon, or Myotomy: Optimal Treatment for Achalasia
292-297
Fundoplication after Laparoscopic Myotomy for Achalasia
298-304
Primary Repair for Delayed Recognition of Esophageal Perforation
305-317
Lengthening Gastroplasty for Managing Gastroesophageal Reflux Disease and Stricture
318-322
Lengthening Gastroplasty for Managing Giant Paraesophageal Hernia
323-331
Management of Zenker’s Diverticulum: Open Versus Transoral Approaches
332-339
Management of Minimally Symptomatic Pulsion Diverticula of the Esophagus
343-384
Part 4 / Diaphragm
343-349
Giant Paraesophageal Hernia: Thoracic, Open Abdominal, or Laparoscopic Approach
350-355
Management of Minimally Symptomatic Giant Paraesophageal Hernias
356-364
Plication for Diaphragmatic Eventration
365-370
Pacing for Unilateral Diaphragm Paralysis
371-378
Optimal Crural Closure Techniques for Repair of Large Hiatal Hernias
379-384
Management of Acute Diaphragmatic Rupture: Thoracotomy Versus Laparotomy
387-405
Part 5 / Airway
387-397
Stenting for Benign Airway Obstruction
398-405
Tracheal Resection for Thyroid or Esophageal Cancer
409-460
Part 6 / Pleura and Pleural Space
409-413
Pleural Sclerosis for Malignant Pleural Effusion: Optimal Sclerosing Agent
414-423
Management of Malignant Pleural Effusion: Sclerosis or Chronic Tube Drainage
424-432
Initial Spontaneous Pneumothorax: Role of Thoracoscopic Therapy
433-441
Intrapleural Fibrinolytics
442-450
Diffuse Malignant Pleural Mesothelioma: The Role of Pleurectomy
451-460
Treatment of Malignant Pleural Mesothelioma: Is There a Benefit to Pleuropneumonectomy?
463-492
Part 7 / Mediastinum
463-468
Management of Myasthenia Gravis: Does Thymectomy Provide Benefit over Medical Therapy Alone?
469-473
Thymectomy for Myasthenia Gravis: Optimal Approach
474-481
Management of Residual Disease after Therapy for Mediastinal Germ Cell Tumor and Normal Serum Markers
482-487
Management of Malignant Pericardial Effusions
488-492
Asymptomatic Pericardial Cyst: Observe or Resect?
495-508
Part 8 / Chest Wall
495-502
Optimal Approach to Thoracic Outlet Syndrome: Transaxillary, Supraclavicular, or Infraclavicular
503-508
Pectus Excavatum in Adults
509-525
Back matter
This page requires script.
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info